Downregulation of HIF-1α by siRNA or a small molecule inhibitor (1-methyl 1, 9 PA) enhances response of CTX-resistant HNSCC cells to CTX plus radiotherapy (161). Here, HIF1A is linked to head and neck squamous cell carcinoma.